HEXIMA LIMITED
Hexima Limited is a company that develops plant-derived proteins and peptides as human antifungal therapeutics.
HEXIMA LIMITED
Social Links:
Industry:
Biotechnology Product Research
Founded:
1998-01-01
Address:
Sydney, New South Wales, Australia
Country:
Australia
Website Url:
http://www.hexima.com.au
Total Employee:
11+
Status:
Active
Contact:
+61 1300 554 474
Email Addresses:
[email protected]
Total Funding:
1.38 M AUD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Government of South Australia
Government of South Australia investment in Debt Financing - Hexima Limited
Official Site Inspections
http://www.hexima.com.au
- Host name: cms106.hostserver.au
- IP address: 202.74.66.186
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney

More informations about "Hexima Limited"
Investor Centre - Hexima
Hexima Limited C/- MUFG Corporate Markets A division of MUFG Pension & Market Services Level 12, 680 George Street, Sydney NSW 2000 Locked Bag A14, Sydney South, NSW 1235. Ph: +61 1300 554 474 Fax: +61 2 9287 0303. โฆSee details»
Contact Us - Hexima
Hexima Share Registry. For more information about your Hexima Limited security holding please contact: Link Market Services Level 12, 680 George Street Sydney NSW 2000 Locked Bag โฆSee details»
Hexima Limited - Crunchbase Company Profile & Funding
Contact Email [email protected]; Phone Number +61 1300 554 474; Hexima is a clinical-stage anti-infectives biotechnology company that is developing plant defensin โฆSee details»
HEXIMA LIMITED. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for HEXIMA LIMITED. of Sydney, NEW SOUTH WALES. Get the latest business insights from Dun & โฆSee details»
Hexima Limited (ASX: HXL) Company Profile & Overview - Stock โฆ
Oct 24, 2024 Hexima Limited does not have significant operations. It focuses on exploration of transactions with third parties, which could enable the value of the companyโs assets. ...See details»
Hexima - Overview, News & Similar companies | ZoomInfo.com
Jun 13, 2023 Hexima contact info: Phone number: +61 394791210 Website: www.hexima.com.au What does Hexima do? Hexima is a biotechnology company actively โฆSee details»
Hexima Limited | ASX Company Profile - Kapitales
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL โฆSee details»
Hexima Limited (ASX:HXL) Information - RocketReach
Hexima is a clinical stage, anti-infectives focused biotechnology company engaged in the research and development of plant defensin peptides for applications as human therapeutics. โฆSee details»
HEXIMA LIMITED (ASX:HXL)
Founding scientist of Hexima. Fellow of the Australian Academy of Science and Australian Academy of Technological Sciences. Member of Hexima board of directors since 2010. DR. โฆSee details»
Hexima Limited - AnnualReports.com
Hexima Limited, a biotechnology company, engages in the research and development of plant-derived proteins and peptides for applications as human therapeutics. The company's lead drug candidate is the plant defensin, โฆSee details»
Hexima Limited (HXL.AX) company profile and facts - Yahoo Finance
Jan 2, 2025 See the company profile for Hexima Limited (HXL.AX), including business summary, industry/sector information, number of employees, corporate governance, key โฆSee details»
Hexima Ltd (ASX:HXL) Share Price - Market Index
Hexima Limited (HXL) is a clinical stage, anti-infectives focused biotechnology company engaged in the research and development of plant defensin peptides for applications as human โฆSee details»
Hexima Limited (HXL.AX) - Yahoo Finance
It focuses on exploration of transactions with third parties, which could enable the value of the company's assets. Previously, the company was involved in the research and development of โฆSee details»
Corporate Presentation - Hexima
Hexima Limited C/- Acclime, Level 3, 62 Lygon Street, Carlton VIC 3053 Australia. Stay up to date. For the latest shareholder information & investor news, subscribe to our email alerts. โฆSee details»
Hexima 2025 Company Profile: Stock Performance & Earnings
Hexima General Information Description. Hexima Ltd is a biotechnology company. The principal activity of the Group during the financial year was the exploration of transactions with third โฆSee details»
Hexima Limited (ASX:HXL) Share Price News - The Motley Fool โฆ
Hexima Ltd Chart and Price Data. Today 5d 1m 3m 6m 1yr 5yr 10yr. Fundamentals Data provided by Morningstar. Data provided by Morningstar. Market Cap $2.17 million. P/E Ratio N/A.See details»
HEXIMA LIMITED ASX ANNOUNCEMENT - miraqle
Jun 24, 2022 an Australian phase IIb clinical trial testing pezadeftide for the treatment of onychomycosis. Hexima holds granted, long-life patents protecting pezadeftide in major โฆSee details»
Hexima Ltd, HXL:ASX profile - FT.com - Financial Times
Oct 24, 2024 Hexima Ltd La Trobe Institute for Molecular Science Level 4, LIMS2, La Trobe University MELBOURNE 3086 Australia AUS; Phone +61 39863-6477; Fax +61 38610-0599; โฆSee details»
Annual & Interim Reports - Hexima
Hexima Limited C/- Acclime, Level 3, 62 Lygon Street, Carlton VIC 3053 Australia. Stay up to date. For the latest shareholder information & investor news, subscribe to our email alerts. โฆSee details»